Accessibility Menu
 
SCYNEXIS logo

SCYNEXIS

(NASDAQ) SCYX

Current Price$0.82
Market Cap$36.31M
Since IPO (2014)-99%
5 Year-89%
1 Year-20%
1 Month+14%

SCYNEXIS Financials at a Glance

Market Cap

$36.31M

Revenue (TTM)

$20.60M

Net Income (TTM)

$8.61M

EPS (TTM)

$-0.14

P/E Ratio

-5.89

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$0.82

Volume

2,080

Open

$0.82

Previous Close

$0.82

Daily Range

$0.81 - $0.84

52-Week Range

$0.56 - $1.31

SCYX News

No articles available.

SCYX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SCYNEXIS

Industry

Pharmaceuticals

Employees

18

CEO

David Angulo Gonzalez, MD

Headquarters

Jersey City, NJ 07302-6548, US

SCYX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-78%

Net Income Margin

-42%

Return on Equity

-16%

Return on Capital

-30%

Return on Assets

-15%

Earnings Yield

-16.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$36.31M

Shares Outstanding

44.66M

Volume

2.08K

Short Interest

0.00%

Avg. Volume

383.36K

Financials (TTM)

Gross Profit

$20.60M

Operating Income

$16.07M

EBITDA

$16.07M

Operating Cash Flow

$5.28M

Capital Expenditure

$0.00

Free Cash Flow

$5.28M

Cash & ST Invst.

$21.26M

Total Debt

$2.17M

SCYNEXIS Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$18.65M

+1808.5%

Gross Profit

$18.65M

+1808.5%

Gross Margin

100.00%

N/A

Market Cap

$36.31M

N/A

Market Cap/Employee

$1.30M

N/A

Employees

28

N/A

Net Income

$12.26M

+376.5%

EBITDA

$10.52M

+381.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$37.94M

-11.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.69M

-22.2%

Short Term Debt

$483.00K

-96.6%

Return on Assets

-14.58%

N/A

Return on Invested Capital

-30.13%

N/A

Free Cash Flow

$18.40M

+285.7%

Operating Cash Flow

$18.40M

+285.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XCURExicure, Inc.
$4.42-4.23%
KLTOKlotho Neurosciences, Inc.
$0.38-7.10%
NRSNNeuroSense Therapeutics Ltd.
$0.73-5.06%
TLPHTalphera, Inc.
$0.74-4.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$167.52-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%

Questions About SCYX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.